AxoGen, Inc. provided earnings guidance for the full year of 2022. For the year, the company continues to expect 2022 revenue will be in the range of $135.0 million to $142.0 million. This represents approximately 10% to 15% growth over 2021 revenue excluding the impact of $4.1 million of Avive revenue in 2021.

Full-year 2022 gross margin is expected to be above 80%.